Trials / Recruiting
RecruitingNCT03818503
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC · Network
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- —
Summary
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.
Conditions
Timeline
- Start date
- 2019-06-24
- Primary completion
- 2026-04-30
- Completion
- 2026-04-30
- First posted
- 2019-01-28
- Last updated
- 2025-03-21
Locations
77 sites across 14 countries: Austria, Belgium, Czechia, France, Germany, Ireland, Israel, Italy, Netherlands, Poland, Slovenia, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT03818503. Inclusion in this directory is not an endorsement.